Day Range151.000 - 155.030 | 52 Wk Range125.360 - 169.980 | Open / Close154.870 / 151.000 | Float / Outstanding54.976M / 62.966M |
Vol / Avg.387.047K / 561.415K | Mkt Cap9.508B | P/E- | 50d Avg. Price155.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float54.976M | EPS-0.270 |
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.
Day Range151.000 - 155.030 | 52 Wk Range125.360 - 169.980 | Open / Close154.870 / 151.000 | Float / Outstanding54.976M / 62.966M |
Vol / Avg.387.047K / 561.415K | Mkt Cap9.508B | P/E- | 50d Avg. Price155.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float54.976M | EPS-0.270 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-03 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-28 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.
Day Range151.000 - 155.030 | 52 Wk Range125.360 - 169.980 | Open / Close154.870 / 151.000 | Float / Outstanding54.976M / 62.966M |
Vol / Avg.387.047K / 561.415K | Mkt Cap9.508B | P/E- | 50d Avg. Price155.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float54.976M | EPS-0.270 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-03 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-28 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.
Day Range151.000 - 155.030 | 52 Wk Range125.360 - 169.980 | Open / Close154.870 / 151.000 | Float / Outstanding54.976M / 62.966M |
Vol / Avg.387.047K / 561.415K | Mkt Cap9.508B | P/E- | 50d Avg. Price155.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float54.976M | EPS-0.270 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-03 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-28 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.
Day Range151.000 - 155.030 | 52 Wk Range125.360 - 169.980 | Open / Close154.870 / 151.000 | Float / Outstanding54.976M / 62.966M |
Vol / Avg.387.047K / 561.415K | Mkt Cap9.508B | P/E- | 50d Avg. Price155.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float54.976M | EPS-0.270 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-03 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-28 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.
Day Range151.000 - 155.030 | 52 Wk Range125.360 - 169.980 | Open / Close154.870 / 151.000 | Float / Outstanding54.976M / 62.966M |
Vol / Avg.387.047K / 561.415K | Mkt Cap9.508B | P/E- | 50d Avg. Price155.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float54.976M | EPS-0.270 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-03 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-28 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.
Day Range151.000 - 155.030 | 52 Wk Range125.360 - 169.980 | Open / Close154.870 / 151.000 | Float / Outstanding54.976M / 62.966M |
Vol / Avg.387.047K / 561.415K | Mkt Cap9.508B | P/E- | 50d Avg. Price155.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float54.976M | EPS-0.270 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-03 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-28 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.
Day Range151.000 - 155.030 | 52 Wk Range125.360 - 169.980 | Open / Close154.870 / 151.000 | Float / Outstanding54.976M / 62.966M |
Vol / Avg.387.047K / 561.415K | Mkt Cap9.508B | P/E- | 50d Avg. Price155.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float54.976M | EPS-0.270 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-03 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-28 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.
Day Range151.000 - 155.030 | 52 Wk Range125.360 - 169.980 | Open / Close154.870 / 151.000 | Float / Outstanding54.976M / 62.966M |
Vol / Avg.387.047K / 561.415K | Mkt Cap9.508B | P/E- | 50d Avg. Price155.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float54.976M | EPS-0.270 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-03 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-28 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.
Day Range151.000 - 155.030 | 52 Wk Range125.360 - 169.980 | Open / Close154.870 / 151.000 | Float / Outstanding54.976M / 62.966M |
Vol / Avg.387.047K / 561.415K | Mkt Cap9.508B | P/E- | 50d Avg. Price155.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float54.976M | EPS-0.270 |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-03 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-28 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.